s6y
Company name or ticker
Search
Cellectar Biosciences, Inc.
4
Chanan-Khan Asher: Statement of changes in beneficial ownership of securities
Filed
Friday, July 2, 2021
Period
Jun 30, 2021
Accession number
0001104659-21-088833
Documents
OWNERSHIP DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header